Purpose: The detection of small renal masses is increasing with the use of crosssectional imaging, although many incidental lesions have negligible metastatic potential. Among malignant masses clear cell renal cell carcinoma is the most prevalent and aggressive subtype. A method to identify such histology would aid in risk stratification. Our goal was to evaluate a likelihood scale for multiparametric magnetic resonance imaging in the diagnosis of clear cell histology. Materials and Methods: We retrospectively reviewed the records of patients with cT1a masses who underwent magnetic resonance imaging and partial or radical nephrectomy from December 2011 to July 2015. Seven radiologists with different levels of experience who were blinded to final pathology findings independently reviewed studies based on a predefined algorithm. They applied a clear cell likelihood score, including 1ddefinitely not, 2dprobably not, 3dequivocal, 4dprobably and 5ddefinitely. Binary classification was used to determine the accuracy of clear cell vs all other histologies. Interobserver agreement was calculated with the weighted k statistic. Results: A total of 110 patients with 121 masses were identified. Mean tumor size was 2.4 cm and 50% of the lesions were clear cell. Defining clear cell as scores of 4 or greater demonstrated 78% sensitivity and 80% specificity while scores of 3 or greater showed 95% sensitivity and 58% specificity. Interobserver agreement was moderate to good with a mean k of 0.53. Conclusions: A clear cell likelihood score used with magnetic resonance imaging can reasonably identify clear cell histology in small renal masses and may decrease the number of diagnostic renal mass biopsies. Standardization of imaging protocols and reporting criteria is needed to improve interobserver reliability. The corresponding author certifies that, when applicable, a statement(s) has been included in the manuscript documenting institutional review board, ethics committee or ethical review board study approval; principles of Helsinki Declaration were followed in lieu of formal ethics committee approval; institutional animal care and use committee approval; all human subjects provided written informed consent with guarantees of confidentiality; IRB approved protocol number; animal approved project number.
1
However, the role of percutaneous biopsy in the management of SRM remains controversial. 2 Recent evidence indicates that while RMB is highly accurate for RCC diagnosis, 3 multiple studies demonstrate underuse. 4, 5 Potential explanations are that RMB is an invasive procedure with a 1.4% to 4.7% complication rate, 3 it fails to provide diagnostic The corresponding author certifies that, when applicable, a statement(s) has been included in the manuscript documenting institutional review board, ethics committee or ethical review board study approval; principles of Helsinki Declaration were followed in lieu of formal ethics committee approval; institutional animal care and use committee approval; all human subjects provided written informed consent with guarantees of confidentiality; IRB approved protocol number; animal approved project number.
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information on malignancy in 14% of cases 6 and it is unreliable for tumor grade determination. 3 Based on excellent soft tissue contrast and a combination of qualitative, semiquantitative and quantitative characteristics mpMRI can histologically subtype RCC. 7e10 As an alternative to computerized tomography mpMRI could potentially provide histological and anatomical information prior to therapeutic intervention, obviating the need for biopsy or additional imaging. However, literature pertaining to the clinical applicability of mpMRI to define higher risk RCC in a SRM is sparse. 7,11e13 Furthermore, to our knowledge the interobserver reproducibility among more than 3 reviewers in the mpMRI evaluation of RCC has not been reported previously. The most common RCC variant is ccRCC, which notably is potentially aggressive. 15 On MRI it is characterized by heterogeneous high signal intensity on T2-weighted imaging, 10 the presence of microscopic fat 16e19 and avid enhancement equal to or greater than that of the renal cortex. 11 Given that the probability of ccRCC diagnosis is proportional to the added effect of individual parameters, a likelihood score based on those MRI parameters might provide a useful tool for patient treatment, as has been done with prostate cancer. 20, 21 Our goal was to evaluate the diagnostic accuracy of a subjective likelihood scale for mpMRI in the diagnosis of ccRCC in cT1a lesions and assess the interreader reproducibility of such scale.
MATERIALS AND METHODS

Patients
This retrospective series was performed under institutional review board approval. We identified patients with cT1a renal masses who underwent partial or radical nephrectomy and preoperative mpMRI between December 2011 and July 2015. Three patients with poor quality or limited MRI examinations (ie not including the sequences described) were excluded from analysis. Patient demographics and clinical findings, including age, gender, tumor size and final pathology results, were extracted from chart review. Histological analysis was performed by genitourinary pathologists according to the WHO classification of renal neoplasms. 22 
Image Acquisition
The mpMRI studies were performed on 1.5 and 3.0 Tesla scanners at multiple institutions with diverse parameters. Many patients underwent mpMRI elsewhere and were referred to our institution for treatment. A total of 54 patients (49%) underwent imaging at our institution while in 56 (51%) imaging was obtained elsewhere. A blinded MRI fellowship trained radiologist who was not involved in imaging interpretation reviewed all mpMRI examinations of patients in this study to ensure that they were of sufficient image quality and basic sequences were included. and fat suppressed, dynamic contrast enhanced T1-weighted imaging, including corticomedullary and late nephrographic, and/or excretory phases in the axial or coronal plane (3 to 6 mm slice thickness, 176 Â 149 to 320 Â 259 matrix size, 1.6 to 2.4 millisecond TE and 3.4 to 5.4 millisecond TR). Because diffusion weighted images were routinely acquired at our institution but inconsistently present in mpMRI studies performed elsewhere, they were not evaluated. Furthermore, given the controversial role of diffusion weighted imaging in characterizing renal masses and the importance of acquisition protocol standardization, 23 these images were not included in analysis.
Image Analysis
Seven radiologists with fellowship training in body MRI from a single institution with a busy MRI service (approximately 7,000 abdominopelvic MRIs per year), varying levels of experience (IP and JRL with 15 years, DC with 12 years, TY with 10 years, GK with 7 years, DFP with 5 years and ADdL with 1 year) and blinded to final pathology results independently reviewed each study on an iSite PACS (picture archiving and communications system) workstation (Philips Healthcare, Best, Netherlands).
A Likert scale was used to convey the subjective radiological impression of the likelihood of encountering ccRCC at surgery. We defined ccLS as 1ddefinitely not ccRCC, 2dprobably not ccRCC, 3dequivocal for ccRCC, 4dprobably ccRCC and 5ddefinitely ccRCC. The term "cannot be assessed" was also allowed if there was perceived inadequacy of the MRI protocol.
Prior to image analysis all radiologists received a refresher training session with a slide presentation, including examples of the main imaging features associated with ccRCC histology and other common histological diagnoses of renal masses. A detailed review of such features was previously reported ( fig. 1) . 24 Each reader measured signal intensity using region of interest analysis and quantified corticomedullary enhancement 11 and the arterial-delayed enhancement ratio according to individual judgment. 25 For statistical purposes a composite ccLS was calculated as a mean of the 7 readers when appropriate.
Statistical Analysis
Scoring each renal mass for the ccRCC diagnosis was compared to the reference standard, which was determined by histology (ccRCC vs all other histologies). ROC analysis was performed to calculate the AUC and the corresponding 95% CI of each reader. Tumors that could not be assessed were excluded from ROC analysis. Multiple comparisons in mean AUCs among readers were done with the Bonferroni correction. Pairwise interobserver agreement was assessed by weighted k statistics.
Statistical significance was considered at p 0.05. All statistical analysis was performed with SASÒ, version 9.4.
RESULTS
We identified 110 patients with a total of 121 cT1a renal masses. Table 1 shows patient demographics and final pathological findings. Mean tumor size was 2.4 cm (range 0.5 to 4.0). Histology revealed ccRCC in 61 cases (50%), nonclear cell RCC in 40 (33%) and benign lesions in 20 (17%). Figure 2 shows the histological distribution of the entire cohort by ccRCC vs all other histologies and the assigned ccLS. Table 2 lists overall ccLS results compared to final histology results. Overall a mean of 2.8 tumors (2.3%) could not be assessed by the reviewers. Tumors with ccLS 4-5 were categorized as mpMRI identified ccRCC. Combining all 7 readers provided 79% mean accuracy, 78% mean sensitivity, and 80% mean specificity, PPV and NPV ( fig. 3) . Augmenting the mpMRI identified ccRCC definition to include ccLS 3 tumors changed mean accuracy to 77%, sensitivity to 95%, specificity to 58%, PPV to 70% and NPV to 93%. This inversely gave ccLS 1-2 a specificity of 95% and a PPV of 93% for all other histologies. Among all readers a mean of 12.2 tumors (10.1%) were false-positive ccLS 4-5 lesions. The most common false-positive histology was oncocytoma in a mean of 2.7 tumors (22.1%) followed by papillary RCC in a mean of 1.3 (10.7%), chromophobe RCC in a mean of 1 (8.2%) and lipid poor AML in a mean of 0.9 (7.4%). A mean of 2.7 tumors (2.2%) per reader were false-negative ccRCC tumors graded as ccLS 1-2, including 50% without high signal intensity on T2-weighted imaging, 79% without high contrast avidity, 100% without intravoxel fat and 84.2% without a central scar, which suggested against higher scoring. Figure 4 shows ROC curves of the 7 readers (AUC 0.82e0.92). Comparisons of the highest rated reader 7 (AUC 0.92) compared to all other readers showed a statistically significant difference among all readers except reader 4. Years of experience did not correlate with improved diagnostic accuracy (p ¼ 0.31). Interreader variability was moderate to good with a mean weighted k of 0.53 (range 0.38e0.64).
DISCUSSION
Multiparametric MRI is an appealing alternative to RMB in that it can provide pathological information to direct management and the anatomical information required for surgical planning. To our knowledge our series is the first to specifically evaluate the diagnostic accuracy of mpMRI for ccRCC in cT1a lesions. The proposed ccRCC likelihood scoring system demonstrated high specificity and PPV for ccRCC in ccLS 4-5 lesions and high specificity of 95% and PPV of 93%) for nonccRCC in ccLS 1-2 lesions in addition to moderate interobserver reliability. Therefore, ccLS could support an algorithm in which all patients with ccLS 4-5 are encouraged to undergo curative intervention, all with ccLS 1-2 are placed on active surveillance, especially if lesions are less than 3 cm, and only those with ccLS 3 undergo RMB. In this series the proposal would result in a biopsy rate of only 20%, unnecessary treatment of oncocytoma and lipid poor AML in 4.5% and 1.7% of the surgical cohort, respectively, It should be noted that ccLS was not a good predictor of overall malignancy. This is expected since it was developed for ccRCC diagnosis. Accordingly while most ccRCCs received a high score, most nonclear cell RCCs were assigned a low score.
In one of the first studies to evaluate a comprehensive classification of renal masses with mpMRI Pedrosa et al defined 8 distinct qualitative mpMRI patterns of malignant lesions among T2-weighted, chemical shift T1-weighted and contrast enhanced T1-weighted sequences. 7 They reported that 2 radiologists demonstrated slightly higher sensitivity and specificity (92% and 83%, respectively) for diagnosing ccRCC compared to our series. Mean size of these 48 ccRCC tumors was much greater than in the current series (6.0 cm) and benign lesions were excluded, which may explain the slightly higher accuracy.
Cornelis et al compared mpMRI scans of 100 renal masses to pathological findings and noted high specificity for diagnosing papillary RCC and oncocytoma. 12 In contrast to our study, they included significant parameters quantified by 2 radiologists and all RCC subtypes were greater than a mean of 4.0 cm.
Recently H€ otker et al reported their evaluation of 124 renal masses by MRI compared to pathological findings. 13 Although median tumor size was 8.0 cm in the ccRCC cohort of 81 patients, they noted that the apparent diffusion coefficient, peak enhancement and the down slope of the dynamic contrast enhanced sequence significantly correlated with ccRCC histology. In addition, after review by 2 independent radiologists they noted significant interreader agreement (r ¼ 0.82e0.99).
Despite the use by other investigators of mpMRI for large (greater than 4.0 cm) renal tumors, in the context of clinical practice we believe that the most relevant application of mpMRI is in classifying SRMs (less than 4.0 cm). In a database of more than 2,700 patients Frank et al noted that 23% of tumors less than 4.0 cm were pathologically benign compared to only 8% of tumors 4.0 cm or greater. 26 Therefore, the current role of RMB is in identifying SRM histology to plan surgical intervention or active surveillance. 27 A recent meta-analysis of RMB demonstrated 4.0% false-positive and 3.1% false-negative rates, in addition to low complication rates, including a 4.9% incidence of hematoma and a 1.2% incidence of pain. 6 However, as mentioned, this was in the context of a 14% nondiagnostic rate. In addition, the histological grade concordance between biopsy and final pathology findings was 52% to 76%. In comparison, our mpMRI results demonstrated 6.2% false-positive and 4.4% false-negative rates, no complications and a 2.3% nondiagnostic rate. As for tumor grade, we did not analyze grade concordance in this initial series. Prior groups have looked at differentiating high and low grade ccRCC in large tumors with good success. 7 To our knowledge the ability to do so in smaller tumors is unknown but likely more difficult.
Additionally, many RMB studies had selection bias as percutaneous biopsy may not be easily performed and/or may carry worse outcomes such as a lower diagnostic yield or increased complications in patients with SRMs in difficult anatomical locations (eg perihilar or anterior), particularly at centers without expertise in performing these procedures. Alternatively mpMRI would potentially avoid additional procedures and the lack of invasiveness might encourage provider use.
The issue of false-positive findings was most notable for oncocytoma, emphasizing the challenge in differentiating it from ccRCC. Similarly Cornelis et al noted difficulty in their retrospective evaluation as 2 radiologists blinded to final pathology results had a diagnostic specificity of 94% but only 19% sensitivity to distinguish ccRCC from oncocytoma. 12 Also, Rosenkrantz et al found no MRI features that would allow the differentiation of oncocytoma from chromophobe RCC using a standard clinical MRI protocol similar to the mpMRI protocols in our study. 28 Further studies, specifically with arterial spin labeling, may have the potential to separate oncocytoma and ccRCC. Although to our knowledge it is not currently commercially available, this technique labels the spin of arterial water, which in effect enables contrast imaging without intravenous tracers. 29 Prior work has shown significant differences in mean arterial spin labeling perfusion levels of oncocytoma and ccRCC. 30 Adding this technique to the mpMRI algorithm may further improve diagnostic accuracy.
As highlighted, most studies of mpMRI have involved at most a few reviewing radiologists. 7, 12 To our knowledge we are the first group to evaluate interreader variability in a large cohort of radiologists. The 7 readers in our series had varying levels of experience ranging from fellowship training to senior faculty (1 to 15 years). However, we found that the radiologist level of experience did not appear to correlate with ccLS accuracy. The reason is speculative but it might reflect the more recent emphasis on mpMRI exposure in residency and fellowship programs. Additionally, the structured algorithm might have mitigated some effects of experience.
For interreader variability we observed good consistency among the radiologists when using the algorithm and ccLS scoring with a mean weighted k of 0.53. However, this also highlights an opportunity for improvement. Given the multitude of adjustable parameters in mpMRI, intercenter standardization is needed to specify imaging protocols that will best characterize SRMs.
Our study has limitations that deserve mention. First is the retrospective design. While our radiologists were blinded to final pathology findings, this structure has inherent bias. Not all patients with a SRM undergo mpMRI so that there was selection bias that could have affected our estimates of RMB (20% for ccLS 3) or unnecessary ccLS 4-5 surgery (6.2%) in this series. In addition, not all patients who had mpMRI were treated with surgery. This selection bias limited our ability to capture benign appearing lesions, which could also affect accuracy. Therefore, the strength of this modality will ultimately depend on a prospective analysis to verify that ccLS can accurately direct SRM management.
The second limitation is that this was a single institution series. As stated, all mpMRI sequences are not equal and standardization is required to improve intercenter reproducibility. However, the reasonable diagnostic accuracy of ccLS is encouraging when considering the multiple mpMRI studies performed at different institutions with different imaging protocols. Future studies should be multi-institutional to ensure stable results among centers.
Finally, our study was small with a cohort of only 121 SRMs, of which 61 were ccRCC. However, compared to other series 7, 12, 13 we report the largest SRM series to date. Larger studies are ultimately needed to define the accuracy of this work.
These limitations notwithstanding, we have found that ccLS can accurately predict ccRCC in cT1a renal masses. In addition to providing anatomical information for surgical planning, this could streamline SRM decision making and obviate the need for additional procedures prior to definitive management. Moreover, our reported technique has good interreader variability. In conclusion, in future prospective and multi-institutional studies we hope to verify these initial results and the generalizability of this technique.
